Avenue Therapeutics Inc (ATXI) is around the top of the Biotechnology industry according to InvestorsObserver. ATXI received an overall rating of 66, which means that it scores higher than 66 percent of all stocks. Avenue Therapeutics Inc also achieved a score of 72 in the Biotechnology industry, putting it above 72 percent of Biotechnology stocks. Biotechnology is ranked 14 out of the 148 industries.
ATXI has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on ATXI!